Skip to main content
Road map for treating rare diseases includes repurposing drugs

Matthew Might, director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham, is drawing on his own experience as the parent of a child with a rare disease to create a framework for others in his situation. Might is a proponent of testing already approved drugs to see whether they work against rare diseases, though he acknowledges identifying treatments for some complex diseases is not so simple and says "there's a gap between diagnostics and therapeutics."

Full Story: